Axel Bolte
Overview
Axel Bolte received an average of $3M in total compensation, including $418K in salary, at Inozyme Pharma from 2019 to 2023.
2023Inozyme PharmaFormer President and Chief Executive Officer
2022Inozyme PharmaFormer President and Chief Executive Officer
2021Inozyme PharmaPresident and Chief Executive Officer
2020Inozyme PharmaPresident and Chief Executive Officer
2019Inozyme PharmaPresident and Chief Executive Officer
Source: SEC filings on April 26, 2024, April 27, 2023, April 27, 2022, and April 27, 2021.
Related executives
We found seven more executives who work or worked at Inozyme Pharma.
Douglas Treco
Inozyme Pharma
Chief Executive Officer
Matthew Winton
Inozyme Pharma
Chief Operating Officer
Sanjay Subramanian
Inozyme Pharma
Chief Financial Officer
Henric Bjarke
Inozyme Pharma
Chief Operating Officer
Deborah Wenkert
Inozyme Pharma
Chief Medical Officer
Steven Jungles
Inozyme Pharma
Former Senior Vice President and Chief Technical Operations Officer
Pedro Huertas
Inozyme Pharma